Search results
Ethic Inc. Has $5.98 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoEthic Inc. increased its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 10.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 38,570 shares of the company ...
AbbVie (ABBV) Laps the Stock Market: Here's Why
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) ended the recent trading session at $170.46, demonstrating a +0.61% swing from the preceding day's closing price. This change outpaced the...
Sanibel Captiva Trust Company Inc. Invests $41.99 Million in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoSanibel Captiva Trust Company Inc. acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to the company in its most recent disclosure ...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 3 days agoAbbVie has made a licence agreement with FutureGen Biopharmaceutical to develop a next-generation...
AbbVie joins in latest gastrointestinal drug chase
BioPharma Dive via Yahoo Finance· 3 days agoAbbVie is securing its place in an emerging gastrointestinal disease drug field, paying China-based FutureGen Biopharmaceutical $150 million in immediate...
Mosley Wealth Management Invests $605,000 in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoMosley Wealth Management purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased ...
Security National Bank of Sioux City Iowa IA Sells 200 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoSecurity National Bank of Sioux City Iowa IA cut its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.4% during the fourth quarter, according to the company ...
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory...
The Port Lavaca Wave· 4 days ago- Global license agreement to focus on the development of FG-M701, a TL1A antibody, for the treatment of inflammatory bowel disease (IBD)
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Cullen Capital Management LLC
ETF DAILY NEWS· 6 days agoCullen Capital Management LLC lifted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.2% during the fourth quarter, according to the company in its most ...
AbbVie Inc. (NYSE:ABBV) Stock Holdings Cut by Waddell & Associates LLC
ETF DAILY NEWS· 7 days agoWaddell & Associates LLC reduced its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 5.8% during the fourth quarter, according to its most recent filing with the Securities ...
